Oct 30 |
Jim Cramer Says Bristol-Myers Squibb Company (BMY) Is ‘Too Low’
|
Oct 29 |
Zai Lab reports positive Chinese study data for KarXT for schizophrenia
|
Oct 29 |
Pfizer raises full-year guidance by $1.5 billion amid activist investor pressure
|
Oct 28 |
Should Bristol Myers Stock Be in Your Portfolio Pre-Q3 Earnings?
|
Oct 28 |
Myriad Genetics (MYGN) Earnings Expected to Grow: Should You Buy?
|
Oct 28 |
Curious about Bristol Myers (BMY) Q3 Performance? Explore Wall Street Estimates for Key Metrics
|
Oct 28 |
Bristol-Myers Squibb Deserves Its Place Among Its Big Pharma Brethren
|
Oct 28 |
Bristol Myers Squibb to Present New Clinical and Health Economics and Outcomes Research Data at Psych Congress 2024
|
Oct 28 |
Earnings week ahead: MSFT, AMZN, AAPL, META, GOOG, AMD, PFE, F, MCD, SBUX, XOM, CVX and more
|
Oct 26 |
Pfizer’s Activist Battle Might Fizzle—but Its Stock Probably Won’t
|